| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |